Sign Up to like & get
recommendations!
1
Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1561869
Abstract: ABSTRACT Introduction: Despite many efforts to improve the outcome of pancreatic ductal adenocarcinoma (PDAC), its prognosis remains poor, which is mostly related to late diagnosis and drug resistance. Improving systemic therapy is considered the major…
read more here.
Keywords:
pharmacotherapeutic strategies;
strategies treating;
treating pancreatic;
pancreatic cancer ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4932
Abstract: Pancreatic cancer remains one of the most lethal malignant cancers because the symptoms of this cancer do not exhibit until the disease progresses to an advanced stage. Late diagnosis may result in metastasis. When metastasis…
read more here.
Keywords:
cell;
pancreatic cancer;
kinase;
treating pancreatic ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5004
Abstract: Background: Pancreatic ductal adenocarcinoma (PDAC) is the second most significant cause of cancer-related mortality, with a 5-year survival rate of just 11%. PDACs are one of the most difficult to treat cancers, mainly because of…
read more here.
Keywords:
small molecule;
ductal adenocarcinoma;
molecule;
pancreatic ductal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Nigerian Journal of Clinical Practice"
DOI: 10.4103/njcp.njcp_444_16
Abstract: Purpose: Pancreatic carcinoma is the most lethal cancer, with a 5-year survival rate of
read more here.
Keywords:
drug reactions;
treating pancreatic;
adr;
cancer ... See more keywords